Alina M. Allen

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona · ORCID：0000-0002-8393-8410

发表论文 216 篇 · 总被引 10828 次 · h-index 47

代表论文

• Semaglutide therapy for metabolic dysfunction–associated steatohepatitis: November 2025 updates to AASLD Practice Guidance (2025 · Hepatology · 被引 66)
• Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries (2025 · Clinical Gastroenterology and Hepatology · 被引 16)
• Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (2026 · Gastroenterology · 被引 10)
• Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes (2025 · JAMA Network Open · 被引 10)
• Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial (2025 · Nature Medicine · 被引 3)
• Clinical and Genetic Predictors of Non‐Alcoholic Steatotic Liver Disease and Fibrosis in Lean Individuals (2025 · Liver International · 被引 2)